SCHACHLE JOSEPH K has filed 6 insider transactions across 1 company since November 2023.
Most recent transaction: a sale of 3719 shares of Opus Genetics, Inc. ($IRD) on March 16, 2026.
Activity breakdown: 1 open-market purchase and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Opus Genetics, Inc. | $IRD | SCHACHLE JOSEPH K | Chief Operating Officer | S | Common Stock | 3719 | $5.25 | 300,781.0000 | 70,636,887 | 1.22% | 0.01% |
| Jan. 22, 2026 | Opus Genetics, Inc. | $IRD | SCHACHLE JOSEPH K | Chief Operating Officer | A | Common Stock | 250000 | $0.00 | 304,500.0000 | 70,636,887 | 458.72% | 0.35% |
| March 13, 2025 | Opus Genetics, Inc. | $IRD | SCHACHLE JOSEPH K | Chief Operating Officer | A | Common Stock | 52500 | $0.00 | 54,500.0000 | 26,715,526 | 2625.00% | 0.20% |
| March 13, 2025 | Opus Genetics, Inc. | $IRD | SCHACHLE JOSEPH K | Chief Operating Officer | A | Employee Stock Option (right to buy) | 52500 | $0.00 | 52,500.0000 | 26,715,526 | 9999.99% | 0.20% |
| March 21, 2024 | Opus Genetics, Inc. | $IRD | SCHACHLE JOSEPH K | Chief Operating Officer | P | Common Stock | 2000 | $2.05 | 2,000.0000 | 21,589,821 | 9999.99% | 0.01% |
| Nov. 27, 2023 | Opus Genetics, Inc. | $IRD | SCHACHLE JOSEPH K | Chief Operating Officer | A | Employee Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |